{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:48:06Z","timestamp":1794649686893,"version":"4.9.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA214608"],"award-info":[{"award-number":["R01CA214608"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA262188"],"award-info":[{"award-number":["R01CA262188"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K99CA287069"],"award-info":[{"award-number":["K99CA287069"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","award":["DRG-2514-24"],"award-info":[{"award-number":["DRG-2514-24"]}],"id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62099-w","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:13:34Z","timestamp":1753370014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Unveiling the hidden interactome of CRBN molecular glues"],"prefix":"10.1038","volume":"16","author":[{"given":"Kheewoong","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Metivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9274-9104","authenticated-orcid":false,"given":"Shourya S.","family":"Roy Burman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Bushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojong","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Lumpkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia K.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah M.","family":"Abeja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Lakshminarayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4347-3193","authenticated-orcid":false,"given":"Hong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-8267","authenticated-orcid":false,"given":"Yuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2478-202X","authenticated-orcid":false,"given":"Alyssa L.","family":"Verano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2830-5650","authenticated-orcid":false,"given":"Anna M.","family":"Schmoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-7403","authenticated-orcid":false,"given":"Nathanael S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8539-5106","authenticated-orcid":false,"given":"Katherine A.","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7337-6306","authenticated-orcid":false,"given":"Eric S.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"62099_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-pharmtox-010715-103507","volume":"57","author":"DP Bondeson","year":"2017","unstructured":"Bondeson, D. P. & Crews, C. M. Targeted protein degradation by small molecules. Annu. Rev. Pharmacol. Toxicol. 57, 107\u2013123 (2017).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"62099_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pharmthera.2017.02.027","volume":"174","author":"TK Neklesa","year":"2017","unstructured":"Neklesa, T. K., Winkler, J. D. & Crews, C. M. Targeted protein degradation by PROTACs. Pharmacol. Ther. 174, 138\u2013144 (2017).","journal-title":"Pharmacol. Ther."},{"key":"62099_CR3","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","volume":"98","author":"KM Sakamoto","year":"2001","unstructured":"Sakamoto, K. M. et al. Protacs: chimeric molecules that target proteins to the Skp1\u2013Cullin\u2013F box complex for ubiquitination and degradation. Proc. Natl. Acad. Sci. 98, 8554\u20138559 (2001).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"62099_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","volume":"81","author":"D Komander","year":"2012","unstructured":"Komander, D. & Rape, M. The ubiquitin code. Annu. Rev. Biochem. 81, 203\u2013229 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"62099_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kronke","year":"2014","unstructured":"Kronke, J. et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301\u2013305 (2014).","journal-title":"Science"},{"key":"62099_CR6","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aab1433","volume":"348","author":"GE Winter","year":"2015","unstructured":"Winter, G. E. et al. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science 348, 1376\u20131381 (2015).","journal-title":"Science"},{"key":"62099_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nchembio.1858","volume":"11","author":"DP Bondeson","year":"2015","unstructured":"Bondeson, D. P. et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat. Chem. Biol. 11, 611 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"62099_CR8","doi-asserted-by":"publisher","first-page":"102811","DOI":"10.1016\/j.sbi.2024.102811","volume":"86","author":"B Wang","year":"2024","unstructured":"Wang, B., Cao, S. & Zheng, N. Emerging strategies for prospective discovery of molecular glue degraders. Curr. Opin. Struct. Biol. 86, 102811 (2024).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"62099_CR9","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito, T. et al. Identification of a primary target of thalidomide teratogenicity. Science 327, 1345\u20131350 (2010).","journal-title":"Science"},{"key":"62099_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13527","volume":"512","author":"ES Fischer","year":"2014","unstructured":"Fischer, E. S. et al. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature 512, 49\u201353 (2014).","journal-title":"Nature"},{"key":"62099_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature18611","volume":"535","author":"ME Matyskiela","year":"2016","unstructured":"Matyskiela, M. E. et al. A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase. Nature 535, 252\u2013257 (2016).","journal-title":"Nature"},{"key":"62099_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nature16979","volume":"532","author":"G Petzold","year":"2016","unstructured":"Petzold, G., Fischer, E. S. & Thoma, N. H. Structural basis of lenalidomide-induced CK1alpha degradation by the CRL4(CRBN) ubiquitin ligase. Nature 532, 127\u2013130 (2016).","journal-title":"Nature"},{"key":"62099_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1126\/science.1244917","volume":"343","author":"G Lu","year":"2014","unstructured":"Lu, G. et al. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343, 305\u2013309 (2014).","journal-title":"Science"},{"key":"62099_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-pharmtox-022123-104147","volume":"64","author":"V Oleinikovas","year":"2024","unstructured":"Oleinikovas, V., Gainza, P., Ryckmans, T., Fasching, B. & Thom\u00e4, N. H. From thalidomide to rational molecular glue design for targeted protein degradation. Annu. Rev. Pharmacol. Toxicol. 64, 291\u2013312 (2024).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"62099_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","volume":"14","author":"ME Matyskiela","year":"2018","unstructured":"Matyskiela, M. E. et al. SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. Nat. Chem. Biol. 14, 981\u2013987 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"62099_CR16","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1182\/blood-2018-01-821769","volume":"132","author":"QL Sievers","year":"2018","unstructured":"Sievers, Q. L., Gasser, J. A., Cowley, G. S., Fischer, E. S. & Ebert, B. L. Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4(CRBN) activity. Blood 132, 1293\u20131303 (2018).","journal-title":"Blood"},{"key":"62099_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature14610","volume":"523","author":"J Kronke","year":"2015","unstructured":"Kronke, J. et al. Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS. Nature 523, 183\u2013188 (2015).","journal-title":"Nature"},{"key":"62099_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15398","volume":"8","author":"J An","year":"2017","unstructured":"An, J. et al. pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4(CRBN) ubiquitin ligase. Nat. Commun. 8, 15398 (2017).","journal-title":"Nat. Commun."},{"key":"62099_CR19","doi-asserted-by":"publisher","unstructured":"Donovan, K. A. et al. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome. Elife 7, https:\/\/doi.org\/10.7554\/elife.38430 (2018).","DOI":"10.7554\/elife.38430"},{"key":"62099_CR20","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41589-020-0645-3","volume":"16","author":"J Yamamoto","year":"2020","unstructured":"Yamamoto, J. et al. ARID2 is a pomalidomide-dependent CRL4CRBN substrate in multiple myeloma cells. Nat. Chem. Biol. 16, 1208\u20131217 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"62099_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/2643-3230.BCD-20-0105","volume":"2","author":"A Renneville","year":"2021","unstructured":"Renneville, A. et al. Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood Cancer Discov. 2, 250\u2013265 (2021).","journal-title":"Blood Cancer Discov."},{"key":"62099_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.omto.2020.06.013","volume":"18","author":"L Li","year":"2020","unstructured":"Li, L. et al. A cereblon modulator CC-885 induces CRBN-and p97-dependent PLK1 degradation and synergizes with volasertib to suppress lung cancer. Mol. Ther. Oncolytics 18, 215\u2013225 (2020).","journal-title":"Mol. Ther. Oncolytics"},{"key":"62099_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.chembiol.2017.10.005","volume":"25","author":"HT Huang","year":"2018","unstructured":"Huang, H. T. et al. A chemoproteomic approach to query the degradable kinome using a multi-kinase degrader. Cell Chem. Biol. 25, 88\u201399 (2018).","journal-title":"Cell Chem. Biol."},{"key":"62099_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.tips.2023.08.007","volume":"44","author":"G Sathe","year":"2023","unstructured":"Sathe, G. & Sapkota, G. P. Proteomic approaches advancing targeted protein degradation. Trends Pharmacol. Sci. 44, 786\u2013801 (2023).","journal-title":"Trends Pharmacol. Sci."},{"key":"62099_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chembiol.2023.02.008","volume":"30","author":"EA King","year":"2023","unstructured":"King, E. A. et al. Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-\u03baB. Cell Chem. Biol. 30, 394\u2013402 (2023).","journal-title":"Cell Chem. Biol."},{"key":"62099_CR26","doi-asserted-by":"crossref","unstructured":"Donovan, K. A. et al. Mapping the degradable kinome provides a resource for expedited degrader development. Cell 183, 1714\u20131731 (2020).","DOI":"10.1016\/j.cell.2020.10.038"},{"key":"62099_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.chembiol.2017.09.010","volume":"25","author":"DP Bondeson","year":"2018","unstructured":"Bondeson, D. P. et al. Lessons in PROTAC design from selective degradation with a promiscuous warhead. Cell Chem. Biol. 25, 78\u201387 (2018).","journal-title":"Cell Chem. Biol."},{"key":"62099_CR28","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41589-018-0055-y","volume":"14","author":"RP Nowak","year":"2018","unstructured":"Nowak, R. P. et al. Plasticity in binding confers selectivity in ligand-induced protein degradation. Nat. Chem. Biol. 14, 706\u2013714 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"62099_CR29","doi-asserted-by":"crossref","unstructured":"Li, Y.-D. et al. Template-assisted covalent modification underlies activity of covalent molecular glues. Nat. Chem. Biol. 20, 1640\u20131649 (2024).","DOI":"10.1038\/s41589-024-01668-4"},{"key":"62099_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-024-07089-6","volume":"627","author":"O Hsia","year":"2024","unstructured":"Hsia, O. et al. Targeted protein degradation via intramolecular bivalent glues. Nature 627, 204\u2013211 (2024).","journal-title":"Nature"},{"key":"62099_CR31","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.chembiol.2021.07.002","volume":"28","author":"Y Xiong","year":"2021","unstructured":"Xiong, Y. et al. Chemo-proteomics exploration of HDAC degradability by small molecule degraders. Cell Chem. Biol. 28, 1514\u20131527 (2021).","journal-title":"Cell Chem. Biol."},{"key":"62099_CR32","doi-asserted-by":"crossref","unstructured":"Huang, H.-T. et al. Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates. Nat. Chem. Biol. 20, 1227\u20131236 (2024).","DOI":"10.1038\/s41589-024-01590-9"},{"key":"62099_CR33","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cell.2015.06.043","volume":"162","author":"EL Huttlin","year":"2015","unstructured":"Huttlin, E. L. et al. The BioPlex network: a systematic exploration of the human interactome. Cell 162, 425\u2013440 (2015).","journal-title":"Cell"},{"key":"62099_CR34","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1038\/s41596-020-0399-0","volume":"15","author":"KF Cho","year":"2020","unstructured":"Cho, K. F. et al. Proximity labeling in mammalian cells with TurboID and split-TurboID. Nat. Protoc. 15, 3971\u20133999 (2020).","journal-title":"Nat. Protoc."},{"key":"62099_CR35","doi-asserted-by":"publisher","first-page":"19.23. 11","DOI":"10.1002\/cpps.51","volume":"91","author":"KJ Roux","year":"2018","unstructured":"Roux, K. J., Kim, D. I., Burke, B. & May, D. G. BioID: a screen for protein-protein interactions. Curr. Protoc. protein Sci. 91, 19.23. 11\u201319.23. 15 (2018).","journal-title":"Curr. Protoc. protein Sci."},{"key":"62099_CR36","doi-asserted-by":"publisher","first-page":"E2453","DOI":"10.1073\/pnas.1406459111","volume":"111","author":"DI Kim","year":"2014","unstructured":"Kim, D. I. et al. Probing nuclear pore complex architecture with proximity-dependent biotinylation. Proc. Natl. Acad. Sci. USA 111, E2453\u2013E2461 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62099_CR37","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1091\/mbc.E15-12-0844","volume":"27","author":"DI Kim","year":"2016","unstructured":"Kim, D. I. et al. An improved smaller biotin ligase for BioID proximity labeling. Mol. Biol. cell 27, 1188\u20131196 (2016).","journal-title":"Mol. Biol. cell"},{"key":"62099_CR38","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.54983","volume":"9","author":"K Kido","year":"2020","unstructured":"Kido, K. et al. AirID, a novel proximity biotinylation enzyme, for analysis of protein\u2013protein interactions. Elife 9, e54983 (2020).","journal-title":"Elife"},{"key":"62099_CR39","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/nbt.2375","volume":"30","author":"JD Martell","year":"2012","unstructured":"Martell, J. D. et al. Engineered ascorbate peroxidase as a genetically encoded reporter for electron microscopy. Nat. Biotechnol. 30, 1143\u20131148 (2012).","journal-title":"Nat. Biotechnol."},{"key":"62099_CR40","doi-asserted-by":"publisher","unstructured":"Sievers, Q. L. et al. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science 362, https:\/\/doi.org\/10.1126\/science.aat0572 (2018).","DOI":"10.1126\/science.aat0572"},{"key":"62099_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00535-013-0931-x","volume":"49","author":"YS Roh","year":"2014","unstructured":"Roh, Y. S., Song, J. & Seki, E. TAK1 regulates hepatic cell survival and carcinogenesis. J. Gastroenterol. 49, 185\u2013194 (2014).","journal-title":"J. Gastroenterol."},{"key":"62099_CR42","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1126\/science.272.5265.1179","volume":"272","author":"H Shibuya","year":"1996","unstructured":"Shibuya, H. et al. TAB1: an activator of the TAK1 MAPKKK in TGF-\u03b2 signal transduction. Science 272, 1179\u20131182 (1996).","journal-title":"Science"},{"key":"62099_CR43","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.chembiol.2019.02.019","volume":"26","author":"G Garivet","year":"2019","unstructured":"Garivet, G. et al. Small-molecule inhibition of the UNC-Src interaction impairs dynamic Src localization in cells. Cell Chem. Biol. 26, 842\u2013851 (2019).","journal-title":"Cell Chem. Biol."},{"key":"62099_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1039\/C3MD00315A","volume":"5","author":"M Golkowski","year":"2014","unstructured":"Golkowski, M. et al. Rapid profiling of protein kinase inhibitors by quantitative proteomics. Medchemcomm 5, 363\u2013369 (2014).","journal-title":"Medchemcomm"},{"key":"62099_CR45","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","volume":"17","author":"F Meier","year":"2020","unstructured":"Meier, F. et al. diaPASEF: parallel accumulation\u2013serial fragmentation combined with data-independent acquisition. Nat. Methods 17, 1229\u20131236 (2020).","journal-title":"Nat. Methods"},{"key":"62099_CR46","unstructured":"Knight, R. In Seminars in oncology. (Elsevier, 2005)."},{"key":"62099_CR47","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D\u2019Amato","year":"1994","unstructured":"D\u2019Amato, R. J., Loughnan, M. S., Flynn, E. & Folkman, J. Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. USA 91, 4082\u20134085 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62099_CR48","doi-asserted-by":"publisher","first-page":"e822","DOI":"10.1016\/S2352-3026(22)00290-3","volume":"9","author":"S Lonial","year":"2022","unstructured":"Lonial, S. et al. Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1\/2 trial.  Lancet Haematol. 9, e822\u2013e832 (2022).","journal-title":"Lancet Haematol."},{"key":"62099_CR49","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa2303194","volume":"389","author":"PG Richardson","year":"2023","unstructured":"Richardson, P. G. et al. Mezigdomide plus dexamethasone in relapsed and refractory multiple myeloma. N. Engl. J. Med. 389, 1009\u20131022 (2023).","journal-title":"N. Engl. J. Med."},{"key":"62099_CR50","first-page":"661","volume":"137","author":"C Surka","year":"2021","unstructured":"Surka, C. et al. CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells. Blood, J. Am. Soc. Hematol. 137, 661\u2013677 (2021).","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"62099_CR51","doi-asserted-by":"publisher","first-page":"11802","DOI":"10.1073\/pnas.1814446115","volume":"115","author":"Y Gemechu","year":"2018","unstructured":"Gemechu, Y. et al. Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs. Proc. Natl. Acad. Sci. USA 115, 11802\u201311807 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62099_CR52","first-page":"779","volume":"126","author":"PR Hagner","year":"2015","unstructured":"Hagner, P. R. et al. CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL. Blood, J. Am. Soc. Hematol. 126, 779\u2013789 (2015).","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"62099_CR53","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41589-021-00802-w","volume":"17","author":"ES Wang","year":"2021","unstructured":"Wang, E. S. et al. Acute pharmacological degradation of Helios destabilizes regulatory T cells. Nat. Chem. Biol. 17, 711\u2013717 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"62099_CR54","doi-asserted-by":"crossref","unstructured":"Costacurta, M. et al. Mapping the IMiD-dependent cereblon interactome using Bio ID-proximity labelling. FEBS J. 291, 4892\u20134912 (2024).","DOI":"10.1111\/febs.17196"},{"key":"62099_CR55","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/bioinformatics\/btu031","volume":"30","author":"P Jones","year":"2014","unstructured":"Jones, P. et al. InterProScan 5: genome-scale protein function classification. Bioinformatics 30, 1236\u20131240 (2014).","journal-title":"Bioinformatics"},{"key":"62099_CR56","doi-asserted-by":"publisher","first-page":"D418","DOI":"10.1093\/nar\/gkac993","volume":"51","author":"T Paysan-Lafosse","year":"2023","unstructured":"Paysan-Lafosse, T. et al. InterPro in 2022. Nucleic Acids Res. 51, D418\u2013D427 (2023).","journal-title":"Nucleic Acids Res."},{"key":"62099_CR57","unstructured":"UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res. 51, D523\u2013D531 (2023)."},{"key":"62099_CR58","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1006\/jmbi.2001.5080","volume":"313","author":"J Gough","year":"2001","unstructured":"Gough, J., Karplus, K., Hughey, R. & Chothia, C. Assignment of homology to genome sequences using a library of hidden Markov models that represent all proteins of known structure. J. Mol. Biol. 313, 903\u2013919 (2001).","journal-title":"J. Mol. Biol."},{"key":"62099_CR59","doi-asserted-by":"crossref","unstructured":"Razumkov, H. et al. Discovery of CRBN-dependent WEE1 molecular glue degraders from a multicomponent combinatorial library. J. Am. Chem. Soc. 146, 31433\u201331443 (2024).","DOI":"10.1021\/jacs.4c06127"},{"key":"62099_CR60","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbrc.2021.02.110","volume":"549","author":"M Zhao","year":"2021","unstructured":"Zhao, M. et al. Cereblon modulator CC-885 induces CRBN-dependent ubiquitination and degradation of CDK4 in multiple myeloma. Biochem. Biophys. Res. Commun. 549, 150\u2013156 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"62099_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18488-4","volume":"11","author":"H Furihata","year":"2020","unstructured":"Furihata, H. et al. Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide. Nat. Commun. 11, 4578 (2020).","journal-title":"Nat. Commun."},{"key":"62099_CR62","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/pro.2610","volume":"24","author":"J Zhou","year":"2015","unstructured":"Zhou, J. & Grigoryan, G. Rapid search for tertiary fragments reveals protein sequence\u2013structure relationships. Protein Sci. 24, 508\u2013524 (2015).","journal-title":"Protein Sci."},{"key":"62099_CR63","doi-asserted-by":"publisher","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","volume":"52","author":"M Varadi","year":"2024","unstructured":"Varadi, M. et al. AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Res. 52, D368\u2013D375 (2024).","journal-title":"Nucleic Acids Res."},{"key":"62099_CR64","doi-asserted-by":"publisher","first-page":"e4548","DOI":"10.1002\/pro.4548","volume":"32","author":"J Zhang","year":"2023","unstructured":"Zhang, J., Schaeffer, R. D., Durham, J., Cong, Q. & Grishin, N. V. DPAM: A domain parser for AlphaFold models. Protein Sci. 32, e4548 (2023).","journal-title":"Protein Sci."},{"key":"62099_CR65","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41592-020-0848-2","volume":"17","author":"JK Leman","year":"2020","unstructured":"Leman, J. K. et al. Macromolecular modeling and design in Rosetta: recent methods and frameworks. Nat. Methods 17, 665\u2013680 (2020).","journal-title":"Nat. Methods"},{"key":"62099_CR66","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/prot.26030","volume":"89","author":"JB Maguire","year":"2021","unstructured":"Maguire, J. B. et al. Perturbing the energy landscape for improved packing during computational protein design. Proteins Struct. Funct. Bioinform. 89, 436\u2013449 (2021).","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"62099_CR67","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1021\/acscentsci.1c00389","volume":"7","author":"FP Rodriguez-Rivera","year":"2021","unstructured":"Rodriguez-Rivera, F. P. & Levi, S. M. Unifying catalysis framework to dissect proteasomal degradation paradigms. ACS Cent. Sci. 7, 1117\u20131125 (2021).","journal-title":"ACS Cent. Sci."},{"key":"62099_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43326-8","volume":"14","author":"O Barroso-Gomila","year":"2023","unstructured":"Barroso-Gomila, O. et al. BioE3 identifies specific substrates of ubiquitin E3 ligases. Nat. Commun. 14, 7656 (2023).","journal-title":"Nat. Commun."},{"key":"62099_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp3000","volume":"10","author":"U Mukhopadhyay","year":"2024","unstructured":"Mukhopadhyay, U. et al. A ubiquitin-specific, proximity-based labeling approach for the identification of ubiquitin ligase substrates. Sci. Adv. 10, eadp3000 (2024).","journal-title":"Sci. Adv."},{"key":"62099_CR70","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41594-023-01206-1","volume":"31","author":"J Liwocha","year":"2024","unstructured":"Liwocha, J. et al. Mechanism of millisecond Lys48-linked poly-ubiquitin chain formation by cullin-RING ligases. Nat. Struct. Mol. Biol. 31, 378\u2013389 (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"62099_CR71","doi-asserted-by":"publisher","unstructured":"Bai, N. et al. Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs. J. Biol. Chem. 298, https:\/\/doi.org\/10.1016\/j.jbc.2022.101653 (2022).","DOI":"10.1016\/j.jbc.2022.101653"},{"key":"62099_CR72","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62099_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27818-z","volume":"13","author":"S Yamanaka","year":"2022","unstructured":"Yamanaka, S. et al. A proximity biotinylation-based approach to identify protein-E3 ligase interactions induced by PROTACs and molecular glues. Nat. Commun. 13, 183 (2022).","journal-title":"Nat. Commun."},{"key":"62099_CR74","doi-asserted-by":"publisher","unstructured":"Yu, H. H. et al. Single subunit degradation of WIZ, a lenalidomide-and pomalidomide-dependent substrate of E3 ubiquitin ligase CRL4CRBN. Preprint at https:\/\/doi.org\/10.1101\/595389 (2019).","DOI":"10.1101\/595389"},{"key":"62099_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/cddiscovery.2017.71","volume":"3","author":"M Cassandri","year":"2017","unstructured":"Cassandri, M. et al. Zinc-finger proteins in health and disease. Cell Death Discov. 3, 1\u201312 (2017).","journal-title":"Cell Death Discov."},{"key":"62099_CR76","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1021\/acs.jmedchem.1c01832","volume":"65","author":"M Teng","year":"2021","unstructured":"Teng, M. et al. Development of PDE6D and CK1\u03b1 degraders through chemical derivatization of FPFT-2216. J. Med. Chem. 65, 747\u2013756 (2021).","journal-title":"J. Med. Chem."},{"key":"62099_CR77","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"62099_CR78","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41586-023-06049-w","volume":"617","author":"J Schmitzov\u00e1","year":"2023","unstructured":"Schmitzov\u00e1, J., Cretu, C., Dienemann, C., Urlaub, H. & Pena, V. Structural basis of catalytic activation in human splicing. Nature 617, 842\u2013850 (2023).","journal-title":"Nature"},{"key":"62099_CR79","doi-asserted-by":"publisher","first-page":"D512","DOI":"10.1093\/nar\/gku1267","volume":"43","author":"PV Hornbeck","year":"2015","unstructured":"Hornbeck, P. V. et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512\u2013D520 (2015).","journal-title":"Nucleic Acids Res."},{"key":"62099_CR80","doi-asserted-by":"crossref","unstructured":"Petzold, G. et al. Mining the CRBN target space redefines rules for molecular glue\u2013induced neosubstrate recognition. Science 389, eadt6736 (2025).","DOI":"10.1126\/science.adt6736"},{"key":"62099_CR81","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/s41591-021-01572-7","volume":"27","author":"T Barak","year":"2021","unstructured":"Barak, T. et al. PPIL4 is essential for brain angiogenesis and implicated in intracranial aneurysms in humans. Nat. Med. 27, 2165\u20132175 (2021).","journal-title":"Nat. Med."},{"key":"62099_CR82","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.molcel.2019.12.013","volume":"77","author":"KM Reichermeier","year":"2020","unstructured":"Reichermeier, K. M. et al. PIKES analysis reveals response to degraders and key regulatory mechanisms of the CRL4 network. Mol. Cell 77, 1092\u20131106 (2020).","journal-title":"Mol. Cell"},{"key":"62099_CR83","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cell.2014.04.037","volume":"157","author":"DC Scott","year":"2014","unstructured":"Scott, D. C. et al. Structure of a RING E3 trapped in action reveals ligation mechanism for the ubiquitin-like protein NEDD8. Cell 157, 1671\u20131684 (2014).","journal-title":"Cell"},{"key":"62099_CR84","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk4422","volume":"383","author":"JA Mercer","year":"2024","unstructured":"Mercer, J. A. et al. Continuous evolution of compact protein degradation tags regulated by selective molecular glues. Science 383, eadk4422 (2024).","journal-title":"Science"},{"key":"62099_CR85","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1126\/science.add7574","volume":"378","author":"ER Watson","year":"2022","unstructured":"Watson, E. R. et al. Molecular glue CELMoD compounds are regulators of cereblon conformation. Science 378, 549\u2013553 (2022).","journal-title":"Science"},{"key":"62099_CR86","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"62099_CR87","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"62099_CR88","doi-asserted-by":"publisher","first-page":"7150","DOI":"10.1021\/ac502040v","volume":"86","author":"GC McAlister","year":"2014","unstructured":"McAlister, G. C. et al. MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal. Chem. 86, 7150\u20137158 (2014).","journal-title":"Anal. Chem."},{"key":"62099_CR89","unstructured":"R: A language and environment for statistical computing (R Foundation for Statistical Computing, 2014)."},{"key":"62099_CR90","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1093\/bioinformatics\/bty355","volume":"34","author":"NA Marze","year":"2018","unstructured":"Marze, N. A., Roy Burman, S. S., Sheffler, W. & Gray, J. J. Efficient flexible backbone protein\u2013protein docking for challenging targets. Bioinformatics 34, 3461\u20133469 (2018).","journal-title":"Bioinformatics"},{"key":"62099_CR91","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson, M. P. et al. A hierarchical approach to all-atom protein loop prediction. Proteins: Struct. Funct. Bioinform. 55, 351\u2013367 (2004).","journal-title":"Proteins: Struct. Funct. Bioinform."},{"key":"62099_CR92","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1021\/acs.jctc.1c00136","volume":"17","author":"EB Miller","year":"2021","unstructured":"Miller, E. B. et al. Reliable and accurate solution to the induced fit docking problem for protein\u2013ligand binding. J. Chem. Theory Comput. 17, 2630\u20132639 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"62099_CR93","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s42003-021-02399-1","volume":"4","author":"R Sanchez-Garcia","year":"2021","unstructured":"Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).","journal-title":"Commun. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62099-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62099-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62099-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:23:31Z","timestamp":1757287411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62099-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62099"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62099-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.S.F. is a founder, scientific advisory board (SAB) member, and equity holder of Civetta Therapeutics, Proximity Therapeutics, Stelexis Biosciences, Neomorph, Inc. (also board of directors), and Anvia Therapeutics (also board of directors). He is an equity holder and SAB member for Avilar Therapeutics, Photys Therapeutics, and Ajax Therapeutics, and an equity holder in Lighthorse Therapeutics, and CPD4 (also board of directors). E.S.F. is a consultant to Novartis, EcoR1 Capital, Odyssey, and Deerfield. The Fischer lab receives or has received research funding from Deerfield, Novartis, Ajax, Interline, Bayer, and Astellas. K.A.D. receives or has received consulting fees from Kronos Bio and Neomorph Inc. N.S.G. is a founder, science advisory board member (SAB), and equity holder in Syros, C4, Allorion, Lighthorse, Inception, Matchpoint, Shenandoah (board member), Larkspur (board member), and Soltego (board member). The Gray lab receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Jansen, Kinogen, Arbella, Deerfield, Springworks, Interline, and Sanofi. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6831"}}